活化蛋白C通过肿瘤细胞外囊泡释放及microRNA-200a转移促进人肺癌进展
该数据集来自NCBI,聚焦活化蛋白C(aPC)促进人肺腺癌进展的机制研究,涉及肿瘤细胞外囊泡释放及microRNA-200a转移

基本信息
资源简介
活化蛋白C通过肿瘤细胞外囊泡释放及microRNA-200a转移促进人肺癌进展
Activated protein C promotes human lung cancer progression through the release of tumor extracellular vesicles and transfer of microRNA-200a
该数据集来自NCBI,聚焦活化蛋白C(aPC)促进人肺腺癌进展的机制研究,涉及肿瘤细胞外囊泡释放及microRNA-200a转移。数据通过高通量测序进行非编码RNA表达谱分析,平台为GPL24676,物种为人(9606)。数据集包含1个文件,样例为GSE303686_series_matrix.txt.gz,可用于探索aPC经EPCR-PAR1-RhoA-ROCKII-JNK1/2-MLC2信号通路调控细胞外囊泡释放及miRNA转移的分子机制,以及肺癌生存、转移和耐药相关研究(来源 NCBI)。
【数据集背景】
源站首次发布:Jul 25 202。
【数据内容】
源站描述(机器翻译,仅供参考):血液凝固与癌症密切相关。与癌症相关的高凝状态导致凝血酶生成异常,从而促进血栓形成。凝血酶还可激活抗凝蛋白C,而活化蛋白C(aPC)除调节凝血途径外,还通过与内皮细胞蛋白C受体(EPCR)结合并激活蛋白酶激活受体1(PAR1)介导的细胞信号传导来引发细胞信号。早期研究表明,aPC促进肺腺癌的生存和转移。然而,其潜在机制在很大程度上仍不清楚。我们目前的研究为aPC如何促进肺腺癌生存、转移和耐药提供了机制见解。我们的研究表明,aPC通过EPCR-PAR1驱动的RhoA-ROCKII-JNK1/2-MLC2信号激活,触发肺腺癌的细胞外囊泡(EV)释放
【数据结构与技术规格】
文件数 1 个,合计 0 B。
【主题与分类】
主题标签:GPL24676、9606。本站分类:肿瘤/肺癌。
【获取与许可】
源站页面:https://ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303686
【使用注意】
· 源站最后修改于 Dec 09 202,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取
源站:https://ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303686
标准获取流程:
- 访问源站链接,注册/登录账号;
- 进入数据集详情页,按页面指引申请权限或直接下载;
- 部分平台提供 SDK,例如:
- OpenDataLab:
pip install openxlab后openxlab.dataset.get(...) - ModelScope:
pip install modelscope后modelscope download - 天池: 登录后页面提供直链下载
以源站「数据下载/使用文档」页面为准。
- OpenDataLab:
数据说明
Blood coagulation and cancer are intricately related. Hypercoagulation associated with cancer leads to aberrant thrombin generation, which contributes to thrombosis. Thrombin also activates anticoagulant protein C and the activated protein C (aPC), in addition to regulating the coagulation pathway, it also elicits cell signaling by binding to endothelial cell protein C receptor (EPCR) and activating protease-activated receptor 1 (PAR1)-mediated cell signaling. Earlier studies showed that aPC promotes lung adenocarcinoma survival and metastasis. However, the underlying mechanism remains largely unknown. Our present study provides mechanistic insight into how aPC promotes lung adenocarcinoma survival, metastasis, and drug resistance. Our study shows that aPC, through EPCR-PAR1-driven activation of RhoA-ROCKII-JNK1/2-MLC2 signaling, triggers extracellular vesicle (EV) release from lung adenocarcinoma cells. aPC-EVs, via the transfer of microRNA (miR)-200a, promote proliferation, migration, and invasion of normal lung epithelial cells. They also confer resistance to lung cancer against chemotherapeutic agents. Inhibition of miR-200a functions through the incorporation of anti-miR-200a abrogates aPC-EVs-mediated tumorigenic effects. Furthermore, loading miR-200a mimic into control EVs showed similar phenotypic responses to that of aPC-EVs. miR-200a is shown to target SOX17 in the recipient cells, leading to tumorigenesis. miR-200a upregulation and SOX17 downregulation are consistently observed in lung cancer tissues in the UALCAN portal database of clinical specimens. Consistent with these findings, our in vivo studies in BALB/c nude mice showed that aPC-EVs from lung cancer cells promote tumor growth, metastasis, and drug resistance through miR-200a transfer. Targeting EV biogenesis, EV’s miR-200a, and/or EV uptake mechanisms may offer novel therapeutic strategies in limiting lung tumorigenesis, thereby increasing patients’ survival.
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




